Document is current
Any future updates will be listed below
-
Authors
Lode, Heidrun Elisabeth
Gjølberg, Torleif Tollefsrud
Foss, Stian
Sivertsen, Magne Sand
Brustugun, Jørgen
Andersson, Yvonne
Jørstad, Øystein Kalsnes
Moe, Morten Carstens
Andersen, Jan Terje
-
Funding
Funding for this research was provided by:
Norges Forskningsråd (251037/F20, 179573, 287927)
Ministry of Health and Care Services | Helse Sør-Øst RHF (2018052)
- License Information
-
More Information
Article History
Received: 24 June 2019
Accepted: 6 November 2019
First Online: 2 December 2019
Competing interests
: Magne S. Sivertsen is an investigator in an Alcon sponsored clinical trial. Øystein K. Jørstad has received lecture fees from Allergan, Alcon, and Bayer, has been a member of a Bayer advisory board and an investigator in an Alcon sponsored clinical trial. Morten C. Moe is member of Bayer and Novartis advisory boards and is an investigator in an Alcon sponsored clinical trial.
